These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36795746)

  • 1. Detachable Dual-Targeting Nanoparticles for Improving the Antitumor Effect by Extracellular Matrix Depletion.
    Duan S; Sun F; Qiao P; Zhu Z; Geng M; Gong X; Li Y; Yao H
    ACS Biomater Sci Eng; 2023 Mar; 9(3):1437-1449. PubMed ID: 36795746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild Acid-Responsive "Nanoenzyme Capsule" Remodeling of the Tumor Microenvironment to Increase Tumor Penetration.
    Yao H; Guo X; Zhou H; Ren J; Li Y; Duan S; Gong X; Du B
    ACS Appl Mater Interfaces; 2020 May; 12(18):20214-20227. PubMed ID: 32248684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan.
    Cun X; Ruan S; Chen J; Zhang L; Li J; He Q; Gao H
    Acta Biomater; 2016 Feb; 31():186-196. PubMed ID: 26675124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Responsive and Deep-Penetrating Nanomicelles for Tumor Therapy via Extracellular Matrix Degradation and Oxidative Stress.
    Wang Z; Xu Y; Wu G; Zuo T; Zhang J; Yang J; Yang Y; Fang T; Shen Q
    ACS Biomater Sci Eng; 2021 Jan; 7(1):166-179. PubMed ID: 33372514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance.
    Liu Y; Zhou Z; Lin X; Xiong X; Zhou R; Zhou M; Huang Y
    Biomacromolecules; 2019 Oct; 20(10):3755-3766. PubMed ID: 31465208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System].
    Li M; Li JP; Wang YS; He Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):577-584. PubMed ID: 34323034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Tumor Site Accumulation and Therapeutic Efficacy of Extracellular Matrix-Drug Conjugates Targeting Tumor Cells.
    Chen Z; Long L; Wang J; Jiang M; Li W; Cui W; Zou L
    Small; 2024 Oct; 20(40):e2402040. PubMed ID: 38829027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemo-Photothermal Combination Cancer Therapy with ROS Scavenging, Extracellular Matrix Depletion, and Tumor Immune Activation by Telmisartan and Diselenide-Paclitaxel Prodrug Loaded Nanoparticles.
    Fang T; Zhang J; Zuo T; Wu G; Xu Y; Yang Y; Yang J; Shen Q
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31292-31308. PubMed ID: 32551473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
    Ruan S; He Q; Gao H
    Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy.
    He Y; Tian X; Fan X; Gong X; Tan S; Pan A; Liang S; Xu H; Zhou F
    ACS Appl Mater Interfaces; 2023 Jan; 15(1):552-565. PubMed ID: 36594282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
    Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
    Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
    Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
    Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed drug delivery system based on optimized "size decrease and hydrophilicity/hydrophobicity transformation" for enhanced hepatocellular carcinoma therapy of doxorubicin.
    Liu Y; Li L; Li L; Zhou Z; Wang F; Xiong X; Zhou R; Huang Y
    Nanomedicine; 2018 Jun; 14(4):1111-1122. PubMed ID: 29458212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
    Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
    Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
    Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
    Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detachable Nanoparticle-Enhanced Chemoimmunotherapy Based on Precise Killing of Tumor Seeds and Normalizing the Growing Soil Strategy.
    Wang L; Ding K; Zheng C; Xiao H; Liu X; Sun L; Omer R; Feng Q; Zhang Z
    Nano Lett; 2020 Sep; 20(9):6272-6280. PubMed ID: 32787161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-Free Nanoagent Interfering with Cancer-Associated Fibroblasts' Metabolism to Promote Tumor Penetration for Boosted Chemotherapy.
    Yu L; Zhou X; Liu Z; Liu H; Zhang XZ; Luo GF; Shang Z
    Nano Lett; 2024 Sep; 24(38):11976-11984. PubMed ID: 39270053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.